記住我
aDivision of Neonatology, Careggi University Hospital of Florence, Florence, Italy
bDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: March 14, 2022
Accepted: July 26, 2022
Published online: September 12, 2022
Issue release date:
Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 0
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
AbstractBackground: We recently demonstrated that oxygen-glucose deprivation (OGD) and unconjugated bilirubin (UCB) can damage mature and immature organotypic hippocampal slices and induce an oxidative stress similar to what occurs in jaundiced term and preterm infants with hypoxic-ischemic encephalopathy (HIE). Objectives: To assess the effects of OGD and UCB on the expression of heme-oxygenase 1 (HO-1) and oxidative stress-related enzymes in an in vitro model of HIE. Methods: Mature and immature organotypic hippocampal slices were exposed to 30-min OGD and to 24 h UCB or UCB plus human serum albumin (HSA). The expression of HO-1, superoxide dismutase 1 (SOD1), catalase (CAT), glutathione peroxidase (GPX), and nuclear factor erythroid-related factor 2 were analyzed by real-time PCR. Results: In mature slices, OGD did not affect the expression of HO-1 and oxidative stress-induced enzymes. The addition of UCB was associated with the upregulation of HO-1 and Nrf2 that is abolished by the presence of equimolar amount of HSA. In immature slices, OGD induced the downregulation of CAT, GPX, and Nrf2 expression and the addition of UCB further decreased GPX. The addition of UCB and HSA reverted the effects of OGD and UCB on gene expression. Conclusions: In an in vitro model of HIE in term infants, we did not observe neuroprotective changes of the expression of HO-1 and genes involved in antioxidant defenses. Conversely, in an in vitro model of HIE in preterm infants, we observed a harmful decrease of the expression of genes encoding for antioxidant enzymes.
© 2022 S. Karger AG, Basel
References Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010;86(6):329–38. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet. 2003;361(9359):736–42. Badawi N, Felix JF, Kurinczuk JJ, Dixon G, Watson L, Keogh JM, et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol. 2005;47(5):293–8. Thornton C, Leaw B, Mallard C, Nair S, Jinnai M, Hagberg H. Cell death in the developing brain after hypoxia-ischemia. Front Cell Neurosci. 2017;11:248. Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169(4):397–403. Thornton C, Baburamani AA, Kichev A, Hagberg H. Oxidative stress and endoplasmic reticulum (ER) stress in the development of neonatal hypoxic-ischaemic brain injury. Biochem Soc Trans. 2017;45(5):1067–76. Riljak V, Kraf J, Daryanani A, Jiruška P, Otáhal J. Pathophysiology of perinatal hypoxic-ischemic encephalopathy: biomarkers, animal models and treatment perspectives. Physiol Res. 2016;65(Suppl 5):S533–545. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043–6. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol. 1991;69(10–11):683–8. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A. 1987;84:5918–22. Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res. 1999;45(3):355–62. Dennery PA, McDonagh AF, Spitz DR, Rodgers PA, Stevenson DK. Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med. 1995;19(4):395–404. Yigit S, Yurdakök M, Kilin K, Oran O, Erdem G, Tekinalp G. Serum malondialdehyde concentration in babies with hyperbilirubinaemia. Arch Dis Child Fetal Neonat Ed. 1999;80(3):F235–237. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 1994;349(2):197–200. Belanger S, Lavoie JC, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biol Neonate. 1997;71(4):233–8. Kumar A, Pant P, Basu S, Rao GRK, Khanna HD. Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr. 2007;53(1):69–71. Basu S, De D, Dev Khanna H, Kumar A. Lipid peroxidation, DNA damage and total antioxidant status in neonatal hyperbilirubinemia. J Perinatol. 2014;34(7):519–23. Doğan M, Peker E, Kirimi E, Sal E, Akbayram S, Erel O, et al. Evaluation of oxidant and antioxidant status in infants with hyperbilirubinemia and kernicterus. Hum Exp Toxicol. 2011;30(11):1751–60. Dani C, Poggi C, Fancelli C, Pratesi S. Changes in bilirubin in infants with hypoxic-ischemic encephalopathy. Eur J Pediatr. 2018;177(12):1795–801. Dani C, Pratesi S, Mannaioni G, Gerace E. Neurotoxicity of unconjugated bilirubin in neonatal hypoxic-ischemic brain injury in vitro. Front Pediatr. 2021;9:659477. Gerace E, Landucci E, Scartabelli T, Moroni F, Pellegrini-Giampietro DE. Rat hippocampal slice culture models for the evaluation of neuroprotective agents. Methods Mol Biol. 2012;846:343–54. Bayer SA, Altman J, Russo RJ, Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology. 1993;14(1):83–144. Gerace E, Landucci E, Totti A, Bani D, Guasti D, Baronti R, et al. Ethanol toxicity during brain development: alterations of excitatory synaptic transmission in immature organotypic hippocampal slice cultures. Alcohol Clin Exp Res. 2016;40(4):706–16. Dani C, Pratesi S, Ilari A, Lana D, Giovannini MG, Nosi D, et al. Neurotoxicity of unconjugated bilirubin in mature and immature rat organotypic hippocampal slice cultures. Neonatology. 2019;115(3):217–25. Landucci E, Filippi L, Gerace E, Catarzi S, Guerrini R, Pellegrini-Giampietro DE. Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo. Neurosci Lett. 2018;668:103–7. Gerace E, Scartabelli T, Formentini L, Landucci E, Moroni F, Chiarugi A, et al. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance. Eur J Neurosci. 2012;36(1):1993–2005. Lapucci A, Cavone L, Buonvicino D, Felici R, Gerace E, Zwergel C, et al. Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice. Neurosci Lett. 2017;656:120–5. Gerace E, Ilari A, Caffino L, Buonvicino D, Lana D, Ugolini F, et al. Ethanol neurotoxicity is mediated by changes in expression, surface localization and functional properties of glutamate AMPA receptors. J Neurochem. 2021;157(6):2106–18. Jasprova J, Dal Ben M, Vianello E, Goncharova I, Urbanova M, Vyroubalova K, et al. The biological effects of bilirubin photoisomers. PLoS One. 2016;11(2):e0148126. Jašprová J, Dal Ben M, Hurný D, Hwang S, Žížalová K, Kotek J, et al. Neuro-inflammatory effects of photodegradative products of bilirubin. Sci Rep. 2018;8(1):7444. Zhang X, Ding M, Zhu P, Huang H, Zhuang Q, Shen J, et al. New insights into the nrf-2/ho-1 signaling axis and its application in pediatric respiratory diseases. Oxid Med Cell Longev. 2019;2019:3214196. Qiu J, Chao D, Sheng S, Khiati D, Zhou X, Xia Y. δ-Opioid receptor-Nrf-2-mediated inhibition of inflammatory cytokines in neonatal hypoxic-ischemic encephalopathy. Mol Neurobiol. 2019;56(7):5229–40. Gao Y, Fu R, Wang J, Yang X, Wen L, Feng J. Resveratrol mitigates the oxidative stress mediated by hypoxic-ischemic brain injury in neonatal rats via Nrf2/HO-1 pathway. Pharm Biol. 2018;56(1):440–9. Tu C, Xu Z, Tian L, Yu Z, Wang T, Guo Z, et al. Multiomics integration to reveal the mechanism of hepatotoxicity induced by dictamnine. Front Cell Dev Biol. 2021;9:700120. Hassan RA, Hozayen WG, Abo Sree HT, Al-Muzafar HM, Amin KA, Ahmed OM. Naringin and hesperidin counteract diclofenac-induced hepatotoxicity in male wistar rats via their antioxidant, anti-inflammatory, and antiapoptotic activities. Oxid Med Cell Longev. 2021;2021:9990091. Deng K, Li Y, Xiao M, Wang F, Zhou P, Zhang W, et al. Lycium ruthenicum Murr polysaccharide protects cortical neurons against oxygen-glucose deprivation/reperfusion in neonatal hypoxic-ischemic encephalopathy. Int J Biol Macromol. 2020;158:562–8. Folkerth RD, Haynes RL, Borenstein NS, Belliveau RA, Trachtenberg F, Rosenberg PA, et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol. 2004;63(9):990–9. Shevtsova A, Gordiienko I, Tkachenko V, Ushakova G. Ischemia-modified albumin: origins and clinical implications. Dis Markers. 2021;2021:9945424. Yao X, Miao W, Li M, Wang M, Ma J, Wang Y, et al. Protective effect of albumin on VEGF and brain edema in acute ischemia in rats. Neurosci Lett. 2010;472(3):179–83. Katavetin P, Inagi R, Miyata T, Tanaka T, Sassa R, Ingelfinger JR, et al. Albumin suppresses vascular endothelial growth factor via alteration of hypoxia-inducible factor/hypoxia-responsive element pathway. Biochem Biophys Res Commun. 2008;367(2):305–10. Negro S, Benders MJNL, Tataranno ML, Coviello C, de Vries LS, van Bel F, et al. Early prediction of hypoxic-ischemic brain injury by a new panel of biomarkers in a population of term newborns. Oxid Med Cell Longev. 2018;2018:7608108. Cascant-Vilaplana MM, Vento M. Seeking biomarkers that predict neurodevelopmental impairment in preterm infants. EBioMedicine. 2021;73:103657. Landucci E, Pellegrini-Giampietro DE, Facchinetti F. Experimental models for testing the efficacy of pharmacological treatments for neonatal hypoxic-ischemic encephalopathy. Biomedicines. 2022;10(5):937. Veskoukis AS, Goutianos G, Paschalis V, Margaritelis NV, Tzioura A, Dipla K, et al. The rat closely mimics oxidative stress and inflammation in humans after exercise but not after exercise combined with vitamin C administration. Eur J Appl Physiol. 2016;116(4):791–804. Gulcan H, Ozturk IC, Arslan S. Alterations in antioxidant enzyme activities in cerebrospinal fluid related with severity of hypoxic ischemic encephalopathy in newborns. Biol Neonate. 2005;88(2):87–91. Article / Publication DetailsFirst-Page Preview
Received: March 14, 2022
Accepted: July 26, 2022
Published online: September 12, 2022
Issue release date:
Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 0
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)